Paper29552191
MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
He RQ and 4 others. Oncol Lett, 2018. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. Papers, record 29552191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29552191
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27547002 | Progress in systemic therapy of advanced hepatocellular carcinoma. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/27547002 | PubMed |
| 2 | 28277897 | High-throughput sequencing reveals circular substrates for an archaeal RNA ligase. | RNA Biol | 2017 | https://conductscience.org/library/papers/28277897 | PubMed |
| 3 | 24172202 | Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. | Ups J Med Sci | 2014 | https://conductscience.org/library/papers/24172202 | PubMed |
| 4 | 27829232 | Circular RNAs and their associations with breast cancer subtypes. | Oncotarget | 2016 | https://conductscience.org/library/papers/27829232 | PubMed |
| 5 | 20981514 | Biological functions of microRNAs: a review. | J Physiol Biochem | 2011 | https://conductscience.org/library/papers/20981514 | PubMed |
| 6 | 27050392 | Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. | Nat Commun | 2016 | https://conductscience.org/library/papers/27050392 | PubMed |
| 7 | 27284128 | Natural language processing: use in EBM and a guide for appraisal. | Evid Based Med | 2016 | https://conductscience.org/library/papers/27284128 | PubMed |
| 8 | 15508102 | Primary liver cancer: worldwide incidence and trends. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15508102 | PubMed |
| 9 | 26884878 | Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26884878 | PubMed |
| 10 | 27258521 | Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27258521 | PubMed |
| 11 | 25689795 | Using circular RNA as a novel type of biomarker in the screening of gastric cancer. | Clin Chim Acta | 2015 | https://conductscience.org/library/papers/25689795 | PubMed |
| 12 | 26600397 | Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. | Cancer Biomark | 2016 | https://conductscience.org/library/papers/26600397 | PubMed |
| 13 | 24805774 | The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24805774 | PubMed |
| 14 | 24211205 | MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. | Biochem Biophys Res Commun | 2013 | https://conductscience.org/library/papers/24211205 | PubMed |
| 15 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 16 | 22940133 | MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. | Biochem Biophys Res Commun | 2012 | https://conductscience.org/library/papers/22940133 | PubMed |
| 17 | 21102580 | The role of microRNAs in liver cancer progression. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21102580 | PubMed |
| 18 | 26263159 | Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study. | Med Sci Monit | 2015 | https://conductscience.org/library/papers/26263159 | PubMed |
| 19 | 26697811 | A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation. | Transpl Int | 2016 | https://conductscience.org/library/papers/26697811 | PubMed |
| 20 | 26125269 | Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma. | Eur Rev Med Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26125269 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40034961 | Evaluation of PI3K Levels and miRNA124-5p Expression Levels in Serum Samples from Patients With Lung Cancer. | Cancer Diagn Progn | 2025 | https://conductscience.org/library/papers/40034961 | PubMed |
| 39598228 | The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39598228 | PubMed |
| 36457743 | Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma. | Front Genet | 2022 | https://conductscience.org/library/papers/36457743 | PubMed |
| 36401966 | Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches. | Transl Oncol | 2023 | https://conductscience.org/library/papers/36401966 | PubMed |
| 35354155 | Reference Genes for qPCR-Based miRNA Expression Profiling in 14 Human Tissues. | Med Princ Pract | 2022 | https://conductscience.org/library/papers/35354155 | PubMed |
| 35309842 | Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217. | Comput Math Methods Med | 2022 | https://conductscience.org/library/papers/35309842 | PubMed |
| 34582363 | Identification of genes and pathways leading to metastasis and poor prognosis in melanoma. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34582363 | PubMed |
| 33949293 | Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma. | Bioengineered | 2021 | https://conductscience.org/library/papers/33949293 | PubMed |
| 33877528 | The potential role of miR-124-3p in tumorigenesis and other related diseases. | Mol Biol Rep | 2021 | https://conductscience.org/library/papers/33877528 | PubMed |
| 33094104 | miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/33094104 | PubMed |
| 33073697 | Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33073697 | PubMed |
| 32244461 | Chronic Regulation of miR-124-3p in the Perilesional Cortex after Experimental and Human TBI. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32244461 | PubMed |
| 31933800 | Overexpression of MiR-452-5p in hepatocellular carcinoma tissues and its prospective signaling pathways. | Int J Clin Exp Pathol | 2019 | https://conductscience.org/library/papers/31933800 | PubMed |
| 31878829 | Long non-coding RNA HOXA11-AS accelerates the progression of keloid formation via miR-124-3p/TGFβR1 axis. | Cell Cycle | 2020 | https://conductscience.org/library/papers/31878829 | PubMed |
| 31389160 | MicroRNA-124: An emerging therapeutic target in cancer. | Cancer Med | 2019 | https://conductscience.org/library/papers/31389160 | PubMed |
| 30387840 | Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking. | Int J Oncol | 2019 | https://conductscience.org/library/papers/30387840 | PubMed |
| 30310513 | The Role of MicroRNAs in Hepatocellular Carcinoma. | J Cancer | 2018 | https://conductscience.org/library/papers/30310513 | PubMed |
| 30108465 | Association between miR-124-1 rs531564 polymorphism and risk of cancer: An updated meta-analysis of case-control studies. | EXCLI J | 2018 | https://conductscience.org/library/papers/30108465 | PubMed |
| 29870138 | Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma. | Thorac Cancer | 2018 | https://conductscience.org/library/papers/29870138 | PubMed |
Genes49
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29552191
GET https://conductscience.org/api/papers/v1/29552191/references?page=2